Sequana Medical N.V. Logo

Sequana Medical N.V.

Develops implantable devices to treat drug-resistant fluid overload from cirrhosis and heart failure.

SEQUA | BR

Overview

Corporate Details

ISIN(s):
BE0974340722
LEI:
8755009AN12Y4PEOII07
Country:
Belgium
Address:
Kortrijksesteenweg 1112 B 102, 9051 Gent
Sector:
Manufacturing
Industry:
Manufacture of medical and dental instruments and supplies

Description

Sequana Medical N.V. is a commercial-stage medical device company pioneering innovative treatments for drug-resistant fluid overload. The company's lead product is the alfapump®, a proprietary, fully-implanted, and wirelessly charged system that automatically and continuously moves excess abdominal fluid (ascites) to the bladder for natural elimination. The alfapump® is the first U.S. FDA-approved active implantable device for treating recurrent or refractory ascites due to liver cirrhosis, and it also holds a CE mark in Europe. The system is designed to significantly reduce or eliminate the need for invasive therapeutic paracentesis procedures and improve patient quality of life. Sequana Medical is also developing its DSR® (Direct Sodium Removal) therapy platform to manage fluid overload in patients with heart failure.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-24 18:30
Major Shareholding Notification
2025-11-13 Transparency Notification BlackRock.pdf
English 284.9 KB
2025-11-24 18:30
Declaration of Voting Results & Voting Rights Announcements
Sequana Medical -- Transparency Notification PR BlackRock (ENG) (24 November 20…
English 296.1 KB
2025-11-24 18:30
Major Shareholding Notification
Sequana Medical -- Transparency Notification PR BlackRock (NL) (24 November 202…
Dutch 311.7 KB
2025-11-14 18:00
Major Shareholding Notification
Sequana Medical -- Fifth GEM Subscription -- Closing PR (ENG) 14 November 2025.…
English 276.3 KB
2025-11-14 18:00
Major Shareholding Notification
Sequana Medical -- Fifth GEM Subscription -- Closing PR (NL) 14 November 2025.p…
Dutch 289.5 KB
2025-08-14 18:00
Declaration of Voting Results & Voting Rights Announcements
Sequana Medical -- Transparency Notification PR BlackRock (ENG) (14 August 2025…
English 289.7 KB
2025-08-14 18:00
Major Shareholding Notification
Sequana Medical -- Transparency Notification PR BlackRock (NL) (14 August 2025)…
Dutch 317.1 KB
2025-08-07 18:00
Share Issue/Capital Change
20250807 Sequana Medical - GEM Subscription Notice PR (ENG).pdf
English 232.0 KB
2025-08-07 18:00
Share Issue/Capital Change
20250807 Sequana Medical - GEM Subscription Notice PR (NL).pdf
Dutch 252.2 KB
2025-07-28 18:00
Declaration of Voting Results & Voting Rights Announcements
Sequana Medical -- Transparency Notification PR BlackRock (ENG) (28 July 2025).…
English 287.8 KB
2025-07-28 18:00
Major Shareholding Notification
Sequana Medical -- Transparency Notification PR BlackRock (NL) (28 July 2025).p…
Dutch 314.8 KB
2025-07-22 18:00
Share Issue/Capital Change
Sequana Medical - Loan Conversions -- Press Release (ENG) (22 July 2025).pdf
English 270.9 KB
2025-07-22 18:00
Share Issue/Capital Change
Sequana Medical - Loan Conversions -- Press Release (NL) (22 July 2025).pdf
Dutch 296.4 KB
2025-07-09 18:00
Declaration of Voting Results & Voting Rights Announcements
Sequana Medical -- Transparency Notification PR BlackRock (ENG) (9 July 2025).p…
English 706.3 KB
2025-07-09 18:00
Major Shareholding Notification
Sequana Medical -- Transparency Notification PR BlackRock (NL) (9 July 2025).pdf
Dutch 711.7 KB

Automate Your Workflow. Get a real-time feed of all Sequana Medical N.V. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Sequana Medical N.V.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Sequana Medical N.V. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2021-06-04 Fin-2K BV Executive member Buy 16,000 N/A
2021-05-27 Crosbie Ian Board Buy 32,000 N/A
2020-09-07 Fin-2K BV Executive member Buy 20,036 N/A
2020-09-04 Crosbie Ian Board Buy 40,073 N/A
2019-06-06 wim ottevaere Board Buy 4,000 25,600.00 EUR
2019-03-29 Fin-2K BV Executive member Buy 20,383 N/A
2019-03-06 Crosbie Ian Board Buy 40,766 N/A
2019-02-26 Chauvineau Pierre Board Buy 10,192 N/A
2019-02-13 wim ottevaere Board Buy 7,000 49,345.10 EUR

Peer Companies

Airway Medix S.A. Logo
Develops single-use devices for mechanically ventilated patients in ICUs and anesthesiology.
Poland
AWM
Alcon AG Logo
Global leader in eye care, offering surgical equipment, contact lenses, and ocular health products.
Switzerland
ALC
Aligned Genetics, Inc. Logo
Develops advanced equipment for cell imaging and diagnostics for research & medicine.
South Korea
238120
Allmed Solutions Ltd. Logo
Develops, manufactures, and markets minimally invasive medical devices and solutions globally.
Israel
ALMD
ALLURION TECHNOLOGIES, INC. Logo
Offers a swallowable gastric balloon & digital platform for non-surgical weight loss.
United States of America
ALUR
Develops & manufactures medical devices, implants, and surgical instruments for global healthcare.
South Korea
043100
Alphatec Holdings, Inc. Logo
Designs and develops innovative medical technologies and procedural solutions for spine surgery.
United States of America
ATEC
Alteco Medical AB Logo
Develops blood purification devices to treat sepsis and septic shock in ICUs.
Sweden
ALTE
Ambu Logo
Develops single-use devices for endoscopy, anesthesia, and patient monitoring to improve safety.
Denmark
AMBU
Amplitude Surgical Logo
Develops and markets high-end orthopedic implants for hip and knee pathologies worldwide.
France
AMPLI

Talk to a Data Expert

Have a question? We'll get back to you promptly.